HF
CTSO icon

Hoxton Financial’s Cytosorbents Corp CTSO Stock Holding History

Hoxton Financial’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$3K Hold
800
– – ﹤0.01% 305
2015
Q4 		$4K Hold
800
– – ﹤0.01% 266
2015
Q3 		$5K Hold
800
– – ﹤0.01% 265
2015
Q2 		$5K Hold
800
– – ﹤0.01% 273
2015
Q1 		$11K Hold
800
– – ﹤0.01% 222
2014
Q4 		$8K Buy
+800
New +$7.83K ﹤0.01% 243

Other funds holding CTSO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIG
American International Group New York $2.93M AUM 12.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Hoxton Financial's CTSO Position: Q1 2016 in Review

Hoxton Financial held its Cytosorbents Corp (CTSO) position steady in Q1 2016 at 800 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #305.

Hoxton Financial first reported a position in CTSO in Q4 2014 and has held it in 6 quarters since. The position peaked at $11K in Q1 2015. 33 funds tracked by Wall St. Rank hold CTSO as of Q1 2016.

  • Hoxton Financial held 800 shares of Cytosorbents Corp worth $3K as of Q1 2016.
  • Hoxton Financial left its Cytosorbents Corp share count unchanged in Q1 2016.
  • Cytosorbents Corp made up ﹤0.01% of Hoxton Financial's portfolio in Q1 2016, its #305 holding.
  • Hoxton Financial first reported a position in Cytosorbents Corp in Q4 2014 and has held it in 6 quarters since.
  • Hoxton Financial's Cytosorbents Corp position peaked at $11K in Q1 2015.
  • 33 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.